178 related articles for article (PubMed ID: 22869145)
1. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.
Ben-Shmuel A; Shvab A; Gavert N; Brabletz T; Ben-Ze'ev A
Oncogene; 2013 Jul; 32(27):3220-30. PubMed ID: 22869145
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.
Gavert N; Ben-Shmuel A; Lemmon V; Brabletz T; Ben-Ze'ev A
J Cell Sci; 2010 Jun; 123(Pt 12):2135-43. PubMed ID: 20501702
[TBL] [Abstract][Full Text] [Related]
3. The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.
Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805564
[TBL] [Abstract][Full Text] [Related]
4. A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
Haase G; Gavert N; Brabletz T; Ben-Ze'ev A
Oncogene; 2017 Mar; 36(11):1597-1606. PubMed ID: 27641335
[TBL] [Abstract][Full Text] [Related]
5. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
6. Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.
Shvab A; Haase G; Ben-Shmuel A; Gavert N; Brabletz T; Dedhar S; Ben-Ze'ev A
Oncogene; 2016 Feb; 35(5):549-57. PubMed ID: 25915847
[TBL] [Abstract][Full Text] [Related]
7. A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression.
Saha A; Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008869
[TBL] [Abstract][Full Text] [Related]
8. Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.
Shapiro B; Tocci P; Haase G; Gavert N; Ben-Ze'ev A
Oncotarget; 2015 Oct; 6(33):34389-401. PubMed ID: 26399194
[TBL] [Abstract][Full Text] [Related]
9. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
10. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling.
Han J; Jogie-Brahim S; Harada A; Oh Y
Cancer Lett; 2011 Aug; 307(2):200-10. PubMed ID: 21536375
[TBL] [Abstract][Full Text] [Related]
12. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
13. TGFβ and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells.
Leiphrakpam PD; Brattain MG; Black JD; Wang J
J Biol Chem; 2018 May; 293(21):8242-8254. PubMed ID: 29599290
[TBL] [Abstract][Full Text] [Related]
14. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.
Gavert N; Sheffer M; Raveh S; Spaderna S; Shtutman M; Brabletz T; Barany F; Paty P; Notterman D; Domany E; Ben-Ze'ev A
Cancer Res; 2007 Aug; 67(16):7703-12. PubMed ID: 17699774
[TBL] [Abstract][Full Text] [Related]
15. NIK- and IKKβ-binding protein promotes colon cancer metastasis by activating the classical NF-κB pathway and MMPs.
Qin M; Liu S; Li A; Xu C; Tan L; Huang J; Liu S
Tumour Biol; 2016 May; 37(5):5979-90. PubMed ID: 26596835
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the Tumor Suppressor TFF1 Is Required during Induction of Colon Cancer Progression by L1.
Saha A; Gavert N; Brabletz T; Ben-Ze'ev A
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139637
[TBL] [Abstract][Full Text] [Related]
17. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
Gavert N; Conacci-Sorrell M; Gast D; Schneider A; Altevogt P; Brabletz T; Ben-Ze'ev A
J Cell Biol; 2005 Feb; 168(4):633-42. PubMed ID: 15716380
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells.
Kim MS; Lee DY
Mol Cell Biochem; 2015 May; 403(1-2):107-13. PubMed ID: 25662950
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of cathepsin D is required for L1-mediated colon cancer progression.
Basu S; Cheriyamundath S; Gavert N; Brabletz T; Haase G; Ben-Ze'ev A
Oncotarget; 2019 Aug; 10(50):5217-5228. PubMed ID: 31497251
[TBL] [Abstract][Full Text] [Related]
20. ISG15 induction is required during L1-mediated colon cancer progression and metastasis.
Cheriyamundath S; Basu S; Haase G; Doernberg H; Gavert N; Brabletz T; Ben-Ze'ev A
Oncotarget; 2019 Dec; 10(67):7122-7131. PubMed ID: 31903170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
